Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Smith, M. R.
Sandhu, S. K.
George, D. J.
Chi, K. N.
Saad, F.
Thiery-Vuillemin, A.
Stahl, O.
Olmos, D.
Danila, D.
Gafanov, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
